NCT01775930 2020-03-04Carfilzomib in Refractory Renal Cell Carcinoma (RCC)M.D. Anderson Cancer CenterPhase 2 Completed10 enrolled 13 charts
NCT00531284 2017-08-15Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaAmgenPhase 1/2 Completed184 enrolled 36 charts